Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments for this devastating childhood cancer.
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies
Posted in biotech/medical